These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characteristics of the binding of N-isopropyl-p-[125I]iodoamphetamine in the rat brain synaptosomal membranes. Mori H; Shiba K; Matsuda H; Tsuji S; Hisada K Nucl Med Commun; 1990 Apr; 11(4):327-31. PubMed ID: 2362745 [TBL] [Abstract][Full Text] [Related]
7. The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production. Holman BL; Wick MM; Kaplan ML; Hill TC; Lee RG; Wu JL; Lin TH J Nucl Med; 1984 Mar; 25(3):315-9. PubMed ID: 6699722 [TBL] [Abstract][Full Text] [Related]
8. Biodistribution of N-isopropyl-p-iodoamphetamine in the rat brain. Hoshi H; Jinnouchi S; Watanabe K; Ueda T; Kinoshita K; Yamaguchi T Nuklearmedizin; 1987 Jun; 26(3):131-4. PubMed ID: 3628020 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of p-iodo-phentermine (IP) as a brain perfusion imaging agent. Kizuka H; Elmaleh DR; Brownell GL; Strauss HW; Hanson RN Nucl Med Commun; 1985 Jan; 6(1):49-56. PubMed ID: 3843616 [TBL] [Abstract][Full Text] [Related]
10. Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals. Moretti JL; Holman BL; Delmon L; Carmel A; Johnson D; Moingeon P; Blau M J Nucl Med; 1987 Mar; 28(3):354-9. PubMed ID: 3029345 [TBL] [Abstract][Full Text] [Related]
11. [Binding sites and subcellular distribution of N-isopropyl-p-(I-125)iodoamphetamine in the rat brain]. Mori H; Shiba K; Tsuji S; Matsuda H; Hisada K Kaku Igaku; 1986 Nov; 23(11):1585-94. PubMed ID: 3820849 [No Abstract] [Full Text] [Related]
12. [Experimental study on liver accumulation of N-isopropyl-p-iodoamphetamine]. Kosuda S; Kawahara S; Ishibashi A; Tamura K; Kubo A; Hashimoto S Kaku Igaku; 1990 Jun; 27(6):599-605. PubMed ID: 2214325 [TBL] [Abstract][Full Text] [Related]
13. Serotonin uptake in cerebral cortex cultures: imipramine-like inhibition by N-isopropyl-p-iodoamphetamine. de Jong BM; Feenstra MG; Ruijter JM; van Royen EA Exp Neurol; 1989 Mar; 103(3):297-9. PubMed ID: 2920796 [TBL] [Abstract][Full Text] [Related]
15. On the theory of the measurement of the first-pass pulmonary extraction using the indicator dilution technique. Akber SF Nuklearmedizin; 1987 Feb; 26(1):20-7. PubMed ID: 2438663 [TBL] [Abstract][Full Text] [Related]
16. Scintigraphic visualization of human malignant melanoma with N-isopropyl-P-[I-123] iodoamphetamine. Wada M; Ichiya Y; Katsuragi M; Kuwabara Y; Ayabe Z; Matsuura K; Takeshita Y Clin Nucl Med; 1985 Jun; 10(6):415-7. PubMed ID: 4017392 [TBL] [Abstract][Full Text] [Related]
17. [Chemical and pharmacological aspects of cerebral cellular tracers]. Rapin JR; Duterte D; Le Poncin-Lafitte M; Coornaert S; Desplanches G; Bardy A; Askienazy S; Moretti JL; Raynaud C Sem Hop; 1983 Dec; 59(48):3361-5. PubMed ID: 6318360 [TBL] [Abstract][Full Text] [Related]
19. A noninvasive assessment of pharmacological interaction of amines in the lung. Akber SF Nucl Med Commun; 1987 Nov; 8(11):889-93. PubMed ID: 3441325 [TBL] [Abstract][Full Text] [Related]